Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non-Small-Cell Lung Cancer: The NVALT-4 Study

Harry J. M. Groen*, Hannie Sietsma, Andrew Vincent, Monique M. H. Hochstenbag, John W. G. van Putten, Anke van den Berg, Otilia Dalesio, Bonne Biesma, Hans J. M. Smit, Arien Termeer, T. Jeroen N. Hiltermann, Ben E. E. M. van den Borne, Franz M. N. H. Schramel

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)4320-4326
JournalJournal of Clinical Oncology
Issue number32
Publication statusPublished - 10 Nov 2011

Cite this